ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NXLIW Nexalin Technologies Inc

0.191
-0.269 (-58.48%)
Jun 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Nexalin Technologies Inc NXLIW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
-0.269 -58.48% 0.191 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.40 0.1707 0.40 0.191 0.46
more quote information »

Recent News

Date Time Source Heading
6/14/202408:53EDGAR2Form S-1/A - General form for registration of securities..
6/13/202414:00GLOBENexalin Technology Announces Regulatory Approval to Sell..
6/12/202412:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/04/202407:30GLOBENexalin Technology to Present at the Spring MicroCap Rodeo..
6/03/202407:30GLOBEFDA Provides Feedback and Reaches Consensus on Nexalin’s..
5/23/202416:17EDGAR2Form S-1 - General form for registration of securities under..
5/22/202407:30GLOBENexalin America Selected to Join the National Traumatic..
5/21/202415:39EDGAR2Form 8-K - Current report
5/14/202415:54EDGAR2Form RW - Registration Withdrawal Request
5/10/202413:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202407:30GLOBEJoin Nexalin Technology’s Exclusive Live Investor Webinar..
4/25/202409:44GLOBENexalin Technology Regains Compliance with Nasdaq Continued..
4/09/202407:30GLOBENexalin Technology Accelerates Manufacturing of its HALO™..
4/04/202412:00GLOBENexalin Technology Awarded Key Patent Related to its Gen-3..
4/02/202407:30GLOBENexalin Technology Announces the Appointment of Government..
3/28/202407:30GLOBENexalin Technology Announces Positive Results of Clinical..
3/14/202407:30GLOBENexalin Technology Commences Sales of Gen-2 Neurostimulation..
3/13/202407:30GLOBENexalin Technology Announces Poster Presentation at “State..
2/08/202407:30GLOBENexalin Technology Announces Regulatory Approval in Oman for..
1/23/202407:30GLOBENexalin Technology Awarded Key Patent Related to its..
1/11/202407:30GLOBENexalin Technology Unveils Next-Generation HALO™ Clarity
12/18/202307:30GLOBENexalin Technology Reports Significant Positive Results of..
10/25/202307:30GLOBENexalin Technology Announces Formation of New Military &..
10/16/202307:30GLOBENexalin Technology Announces Publication of Groundbreaking..
8/07/202307:30GLOBENexalin Technology Reports Results of Clinical Study..
8/03/202307:30GLOBENexalin’s CEO Mark White to be Interviewed Live on “The Big..
7/26/202307:30GLOBENexalin Technology Announces New Public Sector Division to..
7/10/202307:30GLOBENexalin Technology Announces Abstract Accepted for..

Your Recent History